Lantheus Financial Ratios
NASDAQ: LNTHHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lantheus ratio analysis
Lantheus earned a net margin of 15.2% in FY 2025, down from 20.4% a year earlier. Gross margin was 61.1% compared with a median of 50.3% over the prior 9 years. Return on equity reached 21.4%, meaning Lantheus generated 0.21 dollars of profit for every dollar of shareholders' equity.
Debt-to-equity stood at 0.52 versus 0.52 the year before, and the current ratio was 2.70. At the end of FY 2025, LNTH traded at 19.7 times earnings; across the 8 fiscal years shown, its year-end P/E ranged from 6.5 to 127.4, with a median of 17.5. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Lantheus financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| P/E ratio (at fiscal year end) | 19.73 | 20.92 | 13.33 | 127.40 | — | — | 24.29 | 15.24 | 6.45 | 10.49 |
| Price / sales | 2.94 | 4.11 | 3.26 | 3.73 | 4.59 | 2.15 | 2.15 | 1.75 | 2.30 | 0.91 |
| Price / book | 4.17 | 5.80 | 5.19 | 7.81 | 4.20 | 1.42 | 6.53 | 8.45 | 32.73 | — |
| Gross margin | 61.1% | 64.4% | 54.7% | 62.2% | 44.1% | 40.9% | 50.3% | 50.9% | 48.9% | 45.6% |
| Operating margin | 20.2% | 29.8% | 28.1% | 3.9% | -14.3% | -1.2% | 14.9% | 18.8% | 15.6% | 18.7% |
| Net margin | 15.2% | 20.4% | 25.2% | 3.0% | -16.8% | -4.0% | 9.1% | 11.8% | 37.2% | 8.9% |
| Free cash flow margin | 23.0% | 32.1% | 20.0% | 2.3% | 12.7% | 4.8% | 16.8% | 12.0% | 11.2% | 14.0% |
| Return on equity (ROE) | 21.4% | 28.7% | 40.0% | 6.3% | -15.3% | -2.6% | 27.6% | 57.1% | 529.8% | — |
| Return on assets (ROA) | 10.5% | 15.8% | 19.8% | 2.1% | -8.3% | -1.5% | 7.8% | 9.2% | 32.1% | 10.5% |
| Debt / equity | 0.52 | 0.52 | 0.69 | 1.25 | 0.38 | 0.42 | 1.69 | 3.75 | 11.51 | — |
| Current ratio | 2.70 | 5.52 | 5.80 | 2.74 | 2.61 | 2.29 | 2.62 | 3.70 | 3.16 | 2.53 |
| Revenue growth | 0.5% | 18.3% | 38.6% | 119.9% | 25.3% | -2.3% | 1.2% | 3.6% | 9.8% | 2.9% |
| EPS growth | -21.8% | -6.2% | 1,062.5% | — | — | -131.6% | -23.3% | -67.5% | 286.6% | — |